The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The effect of myosin light chain 2 dephosphorylation on Ca-sensitivity of force is enhanced in failing human hearts
Open accessAbstract
OBJECTIVE: Phosphorylation of the myosin light chain 2 (MLC-2) isoform expressed as a percentage of total MLC-2 was decreased in failing (21.1+/-2.0%) compared to donor (31.9+/-4.8%) hearts. To assess the functional implications of this change, we compared the effects of MLC-2 dephosphorylation on force development in failing and non-failing (donor) human hearts. METHODS: Cooperative effects in isometric force and rate of force redevelopment (K(tr)) were studied in single Triton-skinned human cardiomyocytes at various [Ca(2+)] before and after protein phosphatase-1 (PP-1) incubation. RESULTS: Maximum force and K(tr) values did not differ between failing and donor hearts, but Ca(2+)-sensitivity of force (pCa(50)) was significantly higher in failing myocardium (Deltap Ca(50)=0.17). K(tr) decreased with decreasing [Ca(2+)], although this decrease was less in failing than in donor hearts. Incubation of the myocytes with PP-1 (0.5 U/ml; 60 min) decreased pCa(50) to a larger extent in failing (0.20 pCa units) than in donor cardiomyocytes (0.10 pCa units). A decrease in absolute K(tr) values was found after PP-1 in failing and donor myocytes, while the shape of the K(tr)-Ca(2+) relationships remained unaltered. CONCLUSIONS: Surprisingly, the contractile response to MLC-2 dephosphorylation is enhanced in failing hearts, despite the reduced level of basal MLC-2 phosphorylation. The enhanced response to MLC-2 dephosphorylation in failing myocytes might result from differences in basal phosphorylation of other thin and thick filament proteins between donor and failing hearts. Regulation of Ca(2+)-sensitivity via MLC-2 phosphorylation may be a potential compensatory mechanism to reverse the detrimental effects of increased Ca(2+)-sensitivity and impaired Ca(2+)-handling on diastolic function in human heart failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mouse cardiac troponin I (cTnI) is phosphorylated to a greater degree (only ~20–24% un-phosphorylated) than its human counterpart (~44–50% un-phosphorylated)”
From Small and large animal models in cardiac contraction research: advantages and disadvantages (2014) · cites this paper as van der Velden, et al., 2003
Citations
Cites
Brenner, B. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.9.3265 · Cited by 590
Fabiato, A. (1981) · The Journal of General Physiology · doi:10.1085/jgp.78.5.457 · Cited by 568
Bowling, N. L., Walsh, R. A., Song, G., Estridge, T. B., Sandusky, G. E., Fouts, R. L., Mintze, K., Pickard, T., Roden, R. L., Bristow, M. R., et al. (1999) · Circulation · doi:10.1161/01.cir.99.3.384 · Cited by 458
van der Velden, J., Papp, Z., Zaremba, R., Boontje, N. M., DEJONG, J., Owen, V. J., Burton, P., Goldmann, P., Jaquet, K., & Stienen, G. J. M. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00606-5 · Cited by 301
Self-citationIncreased Expression of Cardiac Phosphatases in Patients with End-stage Heart Failure
Neumann, J., Thomas Eschenhagen, A., Jones, L. R., Linck, B., Schmitz, W. L., Scholz, H., & Zimmermann, N. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0271 · Cited by 263
Kirchhefer, U. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00296-x · Cited by 248
Wolff, M. R., Buck, S. H., Stoker, S. W., Greaser, M. L., & Mentzer, R. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118762 · Cited by 229
Myosin light chain phosphorylation affects the structure of rabbit skeletal muscle thick filaments
Levine, R. J. C., Kensler, R. W., Yang, Z., Stull, J. T., & Sweeney, H. L. (1996) · Biophysical Journal · doi:10.1016/s0006-3495(96)79293-7 · Cited by 221
Strang, K. T., Sweitzer, N. K., Greaser, M. L., & Moss, R. L. (1994) · Circulation Research · doi:10.1161/01.res.74.3.542 · Cited by 199
Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit hearts
Garvey, J. L., Kranias, E. G., & Solaro, R. J. (1988) · Biochemical Journal · doi:10.1042/bj2490709 · Cited by 195
Cited by
Sorted by citations
Items 101–147 of 147
Hearts of surviving MLP-KO mice show transient changes of intracellular calcium handling
Kemecsei, P., Miklós, Z., Bı́ró, T., Marincsák, R., Tóth, B. I., Komlódi-Pásztor, E., Barnucz, E., Mirk, É., Vusse, G. J., Ligeti, L., et al. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0492-8 · Cited by 12
Regulatory light chain phosphorylation augments length-dependent contraction in PTU-treated rats
Breithaupt, J. J., Pulcastro, H. C., Awinda, P. O., DeWitt, D. C., & Tanner, B. C. W. (2018) · The Journal of General Physiology · doi:10.1085/jgp.201812158 · Cited by 11
NIMA-related kinase 9 regulates the phosphorylation of the essential myosin light chain in the heart
Müller, M., Eghbalian, R., Boeckel, J., Frese, K., Haas, J., Kayvanpour, E., Sedaghat‐Hamedani, F., Lackner, M. K., Tugrul, O. F., Ruppert, T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33658-2 · Cited by 10
Altered Myocardial Force Generation in End-Stage Human Heart Failure
Papp, Z., van der Velden, J., Borbély, A., Edes, I. F., & Stienen, G. J. M. (2014) · ESC Heart Failure · doi:10.1002/ehf2.12020 · Cited by 10
Self-citationMarkandran, K., Yu, H., Song, W., Lam, D. T. U. H., Madathummal, M. C., & Ferenczi, M. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010088 · Cited by 10
Brixius, K., Lu, R., Boelck, B., Grafweg, S., Hoyer, F., Pott, C., Mehlhorn, U., Bloch, W., & Schwinger, R. H. G. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116798 · Cited by 10
Impact of heart rate on cross-bridge cycling kinetics in failing and nonfailing human myocardium
Chung, J.-H., Milani‐Nejad, N., Davis, J. P., Weisleder, N. L., Whitson, B. A., Mohler, P. J., & Janssen, P. M. L. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00163.2019 · Cited by 8
Self-citationKang, M., & Chung, K. Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.024 · Cited by 8
Wang, S., Wang, H., Su, X., Liu, B., Wang, L., Yan, H., Mao, S., Huang, H., Huang, C., Cheng, M., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110438 · Cited by 8
Stanley, B. A., Graham, D. R. M., James, J. F., Mitsak, M., Tarwater, P. M., Robbins, J., & Eyk, J. E. V. (2011) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201000116 · Cited by 8
Neulen, A., Blaudeck, N., Zittrich, S., Metzler, D., Pfitzer, G., & Stehle, R. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.01.019 · Cited by 8
Sarcomeric remodelling in human heart failure unraveled by single molecule long read sequencing
Haas, J., Schudy, S., Rauscher, B., Verdú, A. M., Roßkopf, S., Reich, C., Dönmez, G., Yalcin, A., Seeger, T., Dieterich, C., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00370-9 · Cited by 6
Cardiac protein changes in rats after soybean oil treatment: a proteomic study
Soprani, T., Uliana, V. K., Ribeiro, E. H., Lisboa, S. M., Maretto, G. X., Ferreira, A., Perales, J., Stefanon, I., & de Figueiredo, S. G. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0024-3 · Cited by 6
Liang, J., Kaźmierczak, K., Rojas, A. I., Wang, Y., & Szczesna‐Cordary, D. (2015) · BioMed Research International · doi:10.1155/2015/742536 · Cited by 6
Ohnuki, Y., Nishimura, S., Sugiura, S., & Saeki, Y. (2008) · The Journal of Physiological Sciences · doi:10.2170/physiolsci.rp012807 · Cited by 6
Heterozygous Mylk3 Knockout Mice Partially Recapitulate Human DCM With Heterozygous MYLK3 Mutations
Tougas, C. L., Grindrod, T., Cai, L. X., Alkassis, F. F., & Kasahara, H. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00696 · Cited by 6
Varian, K. D., Biesiadecki, B. J., Ziolo, M. T., Davis, J. P., & Janssen, P. M. L. (2012) · Biochemistry Research International · doi:10.1155/2012/290971 · Cited by 6
Self-citationRebalancing Protein Phosphorylation in Heart Failure to Prevent Arrhythmias
Sequeira, V., & Maack, C. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1315 · Cited by 6
Updating the Physiology and Pathophysiology of Cardiac Myosin-Binding Protein-C
LeWinter, M. M., & Palmer, B. M. (2015) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002146 · Cited by 6
Kaźmierczak, K., Liang, J., Gomez-Guevara, M., & Szczesna‐Cordary, D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.988066 · Cited by 5
Squarci, C., Koch, D., Anaya, P., Campbell, K. S., & Kampourakis, T. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2520471123 · Cited by 7
The ryanodine receptor microdomain in cardiomyocytes
Dries, E., Gilbert, G., Roderick, H. L., & Sipido, K. R. (2023) · Cell Calcium · doi:10.1016/j.ceca.2023.102769 · Cited by 3
Wang, Y., Zhao, M., Liu, X., Xu, B., Reddy, G. R., Jovanović, A., Wang, Q., Zhu, C., Xu, H., Bayne, E. F., et al. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.03.007 · Cited by 3
What is the In Vivo Mechanism of Action of Levosimendan?
MacGowan, G. A. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.07.001 · Cited by 3
Nano-assault on the heart: Molecular pathways of lead oxide nanoparticle cardiotoxicity
Gerzen, O. P., Nabiev, S. R., Tzybina, A., Potoskueva, I. K., Votinova, V., Klinova, S. V., Minigalieva, I. A., Sutunkova, M. P., & Nikitina, L. V. (2025) · Toxicology Letters · doi:10.1016/j.toxlet.2025.07.1413 · Cited by 2
Prasad, V., Makkaoui, N., Rajan, R., Patel, A., Mainali, B., Bagchi, P., Kumar, R., ROGERS, J. F., Diamond, J., & Maxwell, J. T. (2022) · Physiological Reports · doi:10.14814/phy2.15238 · Cited by 1
Molecular mechanisms of myosin light chain mutation-induced cardiomyopathies
Huang, W. (2015) · Cited by 2
Design Principles and Benefits of Spatially Explicit Models of Myofilament Function
Tanner, B. C. W. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3527-8_4 · Cited by 1
Sarcomeres and the Biophysics of Heart Failure
Simon, J. N., Tardiff, J. C., & Wolska, B. M. (2013) · Biological and medical physics series · doi:10.1007/978-1-4614-7678-8_11 · Cited by 1
The role of myosin regulatory light chain phosphorylation in cardiac health and disease
Toepfer, C. N. (2015) · doi:10.25560/30846 · Cited by 1
van Almen, G. C. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120516ga
Determinants of Progressive Myocardial Deterioration in Human Heart Failure
Hamdani, N. (2009) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Effect of contractile protein alterations on cardiac myofilament function in human heart failure
Narolska, N. A. (2006) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Wijnker, P. J. M., & Sindermann, J. R. (2011)
Eikemo, H. (2009) · NORA - Norwegian Open Research Archives
Myofibrillar Regulatory Mechanisms of Stretch Activation in Mammalian Striated Muscle
Robinett, J. C., Hanft, L. M., & McDonald, K. S. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2016.11.651
Alternations in myocardial function and contractile proteins during human heart failure
Borbély, A. (2005) · University of Debrecen Electronic Archive (University of Debrecen)
Tanner, B. C. W., Awinda, P. O., Agonias, K. B., Blair, C. A., Thompson, M. S., Walker, L. A., Kampourakis, T., & Campbell, K. S. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4088694
Mécanismes physiopathologiques précoces impliqués dans différentes cardiomyopathies induites
Chakouri, N. (2018) · theses.fr (ABES) · doi:10.70675/bd799f01z4569z4c70zb1bbzc15123108d0e
Uddin, M. S., Alnamshan, Y., Shafeen, K., Jahan, S. N., AlMadhi, N., Gurumurthy, K., Hassan, A. B., Esmail, A., & AlQannas, M. A. (2026) · Genes · doi:10.3390/genes17040441
Biomolecular condensation of cMLCK enables myosin motor phosphorylation in the heartPreprint
Carl, K. J., Wellette‐Hunsucker, A. G., Sevrieva, I. R., Campbell, K. S., Fu, X., Ehler, E., & Kampourakis, T. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.21.726954
Evidence for a role of adverse sarcomere signaling in atrial fibrillation induction
McCauley, M. D., & Solaro, R. J. (2026) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2026.100866
Gao, Z., Bao, J., He, C., Pan, H., Zhang, H., & Zhai, C. (2026) · Channels · doi:10.1080/19336950.2026.2746860
Proteomic Technologies and Application to the Study of Heart Disease
McGregor, E., & Dunn, M. J. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-2323-5_2
Metadata
- Authors
- VANDERVELDEN, J., PAPP, Z., BOONTJE, N., ZAREMBA, R., DEJONG, J., JANSSEN, P., HASENFUSS, G., & STIENEN, G.
- Affiliations
- University of Debrecen (HU)
- Amsterdam Cardiovascular Sciences (NL)
- Vrije Universiteit Amsterdam (NL)
- Erasmus University Rotterdam (NL)
- University of Göttingen (DE)
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-02-01
- Volume
- 57
- Issue
- 2
- Pages
- 505-514
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2070092583
- Cited by
- 147
- References
- 34
- Citations by year
- 2026: 6 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 7 · 2021: 6 · 2020: 1 · 2019: 5 · 2018: 7 · 2017: 5 · 2016: 9 · 2015: 12 · 2014: 10 · 2013: 9 · 2012: 6
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion, other-oa)
- GRO (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- myosin light chain 2, calcium sensitivity of contraction, heart failure, protein phosphatase 1, human cardiomyocytes, thin filament regulation, compensatory mechanisms, diastolic function, calcium handling
- MeSH terms
- Adult, Calcium, Cells, Cultured, Female, Heart Failure, Humans, Male, Middle Aged, Myocardial Contraction, Phosphoprotein Phosphatases, Phosphorylation, Electrophoresis, Gel, Two-Dimensional, Myosin Light Chains, Cardiac Myosins, Myocytes, Cardiac, Protein Phosphatase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review